Banks Talk Price on Valeant TLB -
September 14, 2010
A bank consortium has established price talk on a $725 million term loan B for Valeant Pharmaceuticals International...
The full article is available to Leveraged subscribers only
Already a print subscriber? As a print subscriber, you are entitled to online access. Please click here to activate your account.

